GRM1 and schizophrenia: Besides the potential utility of PAMs, it has been reported that also negative allosteric modulators (NAM) of mGluR1 can be efficient in reducing NMDAR-induced hyperlocomotion, deficits in prepulse inhibition, and social interactions in animal models of schizophrenia (Table 2) [42,43,44].